[Relationship between activity of fibrinolysis, parameters of lipid spectrum and carbohydrate metabolism]. 2010

L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov

In this work analysis of results of a prospective populational cohort study "Stress and health in Russia" is presented. We included in the study inhabitants of Moscow randomly sampled from the population of men and women aged > or =55 years. Aim of the present work consisted in the study of relationship of activity of fibrinolysis and main parameters of the system of lipoproteines providing transport of lipids in blood serum and system controlling utilization of glucose by tissues. In dependence on fibrinolytic activity all examined persons were divided into 3 groups: with hypofibrinolysis (group 1, n=41.5%), with normofybrinolysis (group 2, n=41.9%), and hyperfibrinolysis (group 3, n=16.6%). In persons of group 1 low fibrinolytic activity and high level of fibrinogen were combined with atherogenic spectrum of blood serum lipids and elevated level of insulin at normal level of glucose. In patients of group 3 elevated fibrinolytic activity was combined with more favorable composition of blood lipids, lower levels of insulin and glucose and absence of obesity. At study of relation between fibrinoltic activity and a row of clinical states by the method of logistic regression a tendency to elevation of prevalence of myocardial infarction in persons with hypofibrinolysis was found while in persons with hyperfibrinolysis a significant lowering of prevalence of arterial hypertension, ischemic heart disease, and angina pectoris was observed.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003627 Data Interpretation, Statistical Application of statistical procedures to analyze specific observed or assumed facts from a particular study. Data Analysis, Statistical,Data Interpretations, Statistical,Interpretation, Statistical Data,Statistical Data Analysis,Statistical Data Interpretation,Analyses, Statistical Data,Analysis, Statistical Data,Data Analyses, Statistical,Interpretations, Statistical Data,Statistical Data Analyses,Statistical Data Interpretations
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen

Related Publications

L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
January 1968, Journal of atherosclerosis research,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
May 2008, Clinical calcium,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
July 1975, Kardiologiia,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
June 2016, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
April 1987, Bulletin de l'Academie nationale de medecine,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
January 1971, Naunyn-Schmiedebergs Archiv fur Pharmakologie,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
January 1969, Angiologica,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
January 1974, Annual review of physiology,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
June 1977, Infusionstherapie und klinische Ernahrung,
L A Ratnikova, and V A Metel'skaia, and S A Shal'nova, and N V Perova, and A D Deev, and M A Shkol'nikova, and V M Shkol'nikov
September 1959, Nutrition reviews,
Copied contents to your clipboard!